Blog

Podcast

Shehnaaz Suliman, M.D, CEO at ReCode Therapeutics

S2 Episode 6 of BioByteas by Windsor Bux welcomes Shehnaaz Suliman, M.D, CEO at ReCode Therapeutics

In this episode of BioBytes, host Shak sits down with Shehnaaz Suliman, a distinguished biotech executive and the CEO of Recode Therapeutics. Shehnaaz shares her inspiring journey from her beginnings as a physician to spearheading groundbreaking biotech companies. She delves into her commitment to enhancing patient care, the essential qualities needed to build thriving biotech enterprises, the importance of nurturing a culture of innovation, and the value of sustaining strong stakeholder relationships. Additionally, Shehnaaz reflects on the leadership insights she’s gained through overcoming challenges and her enthusiasm for the future of genetic medicine at ReCode.

Takeaways

  • Shehnaaz journey in biotech is driven by a desire to make a difference for patients
  • Key attributes for building biotech companies include curiosity, creativity, and pragmatism
  • A strong company culture is essential for driving results and innovation
  • Building relationships with stakeholders requires alignment, trust, and transparency
  • The importance of hiring a talented and flexible team is crucial for success

You can also listen to this podcast on Spotify:

Welcome to BioBytes – Windsor Bux, where we bring you exclusive interviews with the movers and shakers of the biotech and pharmaceutical industry. Join us as we delve into the experiences and valuable insights of leading executives, exploring how they’re shaping the future and making a difference. Get ready for compelling conversations that will expand your knowledge and inspire your own journey in this exciting field!